Status: Not yet recruiting
T6A Biomarker for Detection of Bacterial Infection in Newborn Infants
This study aims to assess the efficacy of a new biomarker, N6-threonylcarbamoyladenosine (t6A), for the early diagnosis of Early-Onset Sepsis (EOS) in newborns.
Participants needed: 210
Trial details
Biological sex: AllType: ObservationalSponsor: Salzburger LandesklinikenUpdated: Jun 26, 2026Duration: 1 Week
Eligibility criteria
Newborn infants who require blood testing for screening for bacterial infection... [+1]
Refusal to participate in study or not providing written informed consent by car... [+1]